About Conference

Sessions & Tracks

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, parasites, or fungi. These diseases can spread directly or indirectly from person to person, via animal vectors, or through contaminated food, water, and surfaces. Common infectious diseases include influenza, tuberculosis, HIV/AIDS, and COVID-19. Prevention strategies encompass vaccination, good hygiene practices, safe food handling, and vector control. Early detection and treatment are crucial for managing outbreaks and reducing transmission. Antibiotic resistance and emerging pathogens present ongoing challenges, necessitating global cooperation in research, healthcare infrastructure, and public health policies to effectively combat infectious diseases.

Coronavirus Disease (COVID-19)

Coronavirus Disease (COVID-19) is a highly contagious illness caused by the novel coronavirus SARS-CoV-2. First identified in Wuhan, China, in late 2019, it quickly spread globally, leading to an unprecedented pandemic. COVID-19 primarily spreads through respiratory droplets and affects the respiratory system, causing symptoms ranging from mild cough and fever to severe pneumonia and acute respiratory distress syndrome (ARDS). Preventive measures include vaccination, wearing masks, hand hygiene, and social distancing. While vaccines have significantly reduced severe cases and deaths, the emergence of new variants necessitates ongoing vigilance and adaptation in public health strategies.

Nosocomial Infections & Control

Nosocomial infections, also known as hospital-acquired infections (HAIs), occur in healthcare settings such as hospitals and nursing homes. They pose a significant risk to patients, leading to increased morbidity, mortality, and healthcare costs. Common nosocomial infections include urinary tract infections, surgical site infections, and pneumonia. Effective control measures are essential to prevent HAIs, including stringent hand hygiene, proper sterilization of medical equipment, and adherence to infection control protocols. Regular training for healthcare workers and the implementation of antibiotic stewardship programs are also crucial in reducing the incidence of these infections, ensuring patient safety, and improving overall healthcare quality.

Viral Infectious Diseases

Viral infectious diseases are caused by viruses, microscopic agents that invade living cells to reproduce. These diseases include influenza, HIV/AIDS, COVID-19, hepatitis, and measles, each varying in transmission, symptoms, and severity. Viruses spread through respiratory droplets, blood, bodily fluids, or contaminated surfaces. Preventative measures such as vaccinations, good hygiene, and antiviral medications are crucial in controlling viral infections. While some viral diseases, like the common cold, are mild, others can lead to serious health complications and even death. Advances in medical research continuously seek effective treatments and vaccines to mitigate the impact of these pervasive pathogens.

Parasitology & Infectious Diseases

Parasitology and Infectious Diseases is a crucial field of medical science that explores the complex interactions between hosts and parasites, including viruses, bacteria, fungi, and protozoa. This discipline is vital for understanding diseases such as malaria, leishmaniasis, and schistosomiasis, which have significant global health impacts. Researchers focus on disease mechanisms, transmission methods, and the development of innovative treatments and preventive measures. The study of parasitic life cycles and their adaptation strategies offers insights into combating drug resistance and emerging infections. Advances in diagnostics, vaccines, and therapeutics are central to mitigating the burden of these diseases on affected populations worldwide.

Tropical Infectious Diseases

Tropical infectious diseases are illnesses prevalent in or originating from tropical and subtropical regions. These diseases, such as malaria, dengue fever, and chikungunya, are primarily spread through vectors like mosquitoes and ticks. The warm and humid climates of these regions provide ideal breeding grounds for these vectors, facilitating disease transmission. Tropical diseases often pose significant health challenges due to limited access to healthcare, poor sanitation, and rapid urbanization. Effective prevention and control strategies include vector control, vaccination, public health education, and improved healthcare infrastructure. Global efforts and research are crucial in combating these diseases and reducing their impact on affected populations.

Pediatric Infectious Diseases

Pediatric Infectious Diseases focuses on the diagnosis, treatment, and prevention of infections in children, from newborns to adolescents. These infections can range from common illnesses like influenza and strep throat to serious conditions such as meningitis and tuberculosis. Pediatric infectious disease specialists are crucial in managing these illnesses, particularly for children with complex medical conditions or weakened immune systems. They employ advanced diagnostic techniques and tailor treatments to the unique needs of young patients. Additionally, they play a pivotal role in vaccine advocacy and public health, aiming to prevent outbreaks and protect the well-being of the pediatric population through education and immunization programs.

Bacterial Infectious Diseases

Bacterial infectious diseases are caused by pathogenic bacteria invading the body. These diseases range from mild to severe and can affect various organs and systems. Common examples include tuberculosis, caused by Mycobacterium tuberculosis, and strep throat, caused by Streptococcus pyogenes. Transmission occurs through direct contact, contaminated food or water, or inhalation of airborne particles. Symptoms vary but often include fever, fatigue, and localized pain or inflammation. Diagnosis typically involves bacterial cultures or molecular techniques, while treatment usually requires antibiotics. Prevention includes proper hygiene, vaccinations, and safe food practices. Emerging antibiotic resistance poses a significant challenge to managing these diseases effectively.

Fungal Infectious Diseases

Fungal infectious diseases, caused by various fungi, pose significant threats to human health. They encompass a broad spectrum of conditions, from superficial skin infections to life-threatening systemic diseases. Common fungal infections include athlete's foot, ringworm, and candidiasis. However, more severe illnesses like aspergillosis and cryptococcosis can affect vital organs and compromise immune-compromised individuals. Treatment typically involves antifungal medications, but drug resistance and adverse effects are growing concerns. Prevention strategies emphasize personal hygiene, avoiding contaminated environments, and managing underlying conditions such as diabetes or HIV/AIDS. Awareness, early detection, and prompt treatment are pivotal in mitigating the impact of fungal infections on public health.

Veterinary Diseases

Veterinary diseases encompass a spectrum of conditions affecting animals, from common ailments like kennel cough in dogs to more severe illnesses like feline leukemia. These diseases can stem from various sources, including bacteria, viruses, parasites, and environmental factors. For instance, rabies, a viral disease, poses a significant threat to both animals and humans. Timely vaccination is crucial in preventing such outbreaks. Additionally, conditions like heartworm disease highlight the importance of preventative measures such as regular parasite control. Veterinary professionals play a vital role in diagnosing, treating, and preventing these diseases, ensuring the well-being of our beloved animal companions.

Neuro Infectious Diseases

Neuroinfectious diseases, spanning from meningitis to encephalitis, present complex challenges at the intersection of neurology and infectious diseases. These conditions, often caused by viruses, bacteria, fungi, or parasites, can lead to severe neurological complications, including inflammation of the brain or spinal cord. Diagnosis requires a nuanced understanding of both infectious agents and neurological symptoms. Treatment typically involves antimicrobial agents or antiviral medications, alongside supportive care to manage neurological manifestations. Despite advancements, these diseases remain formidable foes, demanding ongoing research to enhance diagnostic techniques, treatment modalities, and preventative strategies, safeguarding public health and preserving neurological well-being.

Research on Medicine and Vaccine for Covid-19

In the global fight against COVID-19, extensive research efforts have been dedicated to developing effective medicines and vaccines. Scientists worldwide have collaborated to understand the virus's behavior and structure, facilitating the development of treatments like antiviral drugs and monoclonal antibodies. Vaccines have also emerged as crucial tools in preventing COVID-19 transmission, with various formulations leveraging mRNA, viral vector, and protein subunit technologies. Rigorous clinical trials ensure safety and efficacy before widespread distribution. These advancements represent a testament to human ingenuity and the power of collaborative scientific endeavors in combating this unprecedented health crisis.

Vaccines and Vaccination

Vaccines and vaccination represent humanity's triumph over infectious diseases. These ingenious biological agents bolster the body's defenses, preparing it to combat specific pathogens. Through the introduction of weakened or inactive forms of viruses or bacteria, vaccines prompt the immune system to produce antibodies, creating immunity without causing illness. This preventative measure has saved countless lives, eradicating diseases like smallpox and nearly eliminating others such as polio. However, vaccine hesitancy persists, fueled by misinformation and fear. Effective vaccination campaigns hinge on education, accessibility, and trust in scientific consensus. Embracing vaccination is not just a personal choice but a collective responsibility towards global health.

Infectious Diseases Prevention, Control and Cure

Preventing, controlling, and curing infectious diseases requires a multifaceted approach. First, rigorous vaccination campaigns bolster immunity against prevalent pathogens. Second, public health measures like sanitation and hygiene practices mitigate transmission. Third, prompt identification and isolation of cases limit spread. Fourth, ongoing research fosters innovative treatments and vaccines. Lastly, community education fosters awareness and cooperation. Together, these strategies form a robust defense against infectious diseases, ensuring public health resilience. Vigilance, collaboration, and investment in healthcare infrastructure are vital for sustainable disease control and eventual eradication.

Infection, Immunity and Inflammation

Infection, immunity, and inflammation constitute a triad crucial to human health. Infection, often caused by pathogens, triggers the immune system's response. Immunity, the body's defense mechanism, involves a complex interplay of cells and molecules, aiming to neutralize or eliminate invading agents. Inflammation, a hallmark of immune response, manifests as redness, swelling, and heat, serving to contain and eliminate pathogens. However, deregulated inflammation can lead to chronic diseases. Understanding this triad is pivotal in developing strategies for combating infections, enhancing immunity, and managing inflammatory conditions, ultimately safeguarding human health and well-being.

Epidemiology

Epidemiology, the study of disease distribution and determinants in populations, is crucial for public health. It investigates patterns, causes, and effects to develop strategies for disease control and prevention. By analyzing factors like demographics, behavior, and environment, epidemiologists identify risk factors and trends, aiding in the development of targeted interventions. From tracking outbreaks to assessing the efficacy of health interventions, epidemiology informs policymaking and healthcare practices. Its interdisciplinary approach integrates statistics, biology, and social sciences, offering insights into complex health issues. Ultimately, epidemiology plays a pivotal role in safeguarding public health and improving quality of life worldwide.

Infectious Diseases Epidemiology

Infectious diseases epidemiology is the study of the patterns, causes, and effects of diseases that spread among populations. It involves analyzing factors such as transmission routes, host susceptibility, and environmental influences to understand how diseases spread and can be controlled. This field plays a crucial role in public health by informing strategies for disease prevention, surveillance, and outbreak response. Through the use of epidemiological methods like surveillance, modeling, and statistical analysis, researchers and public health officials can identify trends, assess risk factors, and develop interventions to mitigate the impact of infectious diseases on communities.

Clinical Management of Infectious Diseases

Clinical management of infectious diseases encompasses various strategies aimed at diagnosing, treating, and preventing the spread of infectious agents. This multifaceted approach includes accurate diagnosis through laboratory testing and clinical evaluation, followed by appropriate antimicrobial therapy tailored to the specific pathogen and patient factors. Additionally, infection control measures such as isolation precautions, hand hygiene, and environmental disinfection play crucial roles in limiting transmission. Furthermore, vaccination, prophylactic antibiotics, and health education contribute significantly to disease prevention. Continuous monitoring of treatment response and adherence, coupled with vigilant surveillance for emerging infections, are integral components of effective infectious disease management protocols.

Internal Medicine for Infectious Diseases

Internal Medicine encompasses a broad spectrum of diseases, with Infectious Diseases being a crucial area. This specialty focuses on diagnosing and treating illnesses caused by pathogens like bacteria, viruses, fungi, and parasites. Practitioners delve into complex cases such as HIV/AIDS, tuberculosis, malaria, and emerging infectious threats like COVID-19. Treatment strategies often involve antimicrobial medications, vaccines, and infection control measures. Internal Medicine specialists in Infectious Diseases play pivotal roles in patient care, public health initiatives, and research endeavors to combat infectious threats, ensuring optimal outcomes for individual patients and communities at large. Their expertise is indispensable in safeguarding global health.

Causes and Symptoms of Infectious Diseases

Infectious diseases are caused by pathogenic microorganisms such as bacteria, viruses, fungi, and parasites. These pathogens spread through various means including direct contact, airborne transmission, contaminated food or water, and insect bites. Symptoms of infectious diseases vary depending on the specific pathogen and can include fever, fatigue, coughing, diarrhea, rash, and more severe manifestations. Some infectious diseases can be easily treated with antibiotics or antiviral medications, while others may require more extensive medical intervention. Prevention strategies such as vaccination, good hygiene practices, and public health measures are crucial in controlling the spread of infectious diseases and reducing their impact on individuals and communities.

Pharmacology of Infectious Diseases

The pharmacology of infectious diseases encompasses the study of medications used to treat microbial infections, including bacteria, viruses, fungi, and parasites. Antibiotics are pivotal in combating bacterial infections by targeting specific bacterial components or metabolic processes. Antiviral drugs inhibit viral replication or entry into host cells, reducing the severity and duration of viral illnesses. Antifungal agents tackle fungal infections by disrupting fungal cell walls or membranes. Similarly, antiparasitic drugs act against various parasites, such as protozoa and helminths, by interfering with their metabolic pathways or life cycles. Understanding the mechanisms of action and pharmacokinetics of these drugs is crucial for effective treatment and combating antimicrobial resistance.

Clinical and Case Reports

Clinical and case reports serve as vital pillars in medical literature, offering profound insights into rare conditions, innovative treatments, and challenging diagnoses. These narratives weave intricate details of patient history, symptoms, diagnostic methods, and therapeutic interventions. Through meticulous documentation, they illuminate the complexities of medical practice, fostering a deeper understanding of disease dynamics and treatment outcomes. Moreover, they provide invaluable learning opportunities for clinicians, guiding future approaches to patient care and enhancing medical knowledge. By encapsulating the nuances of individual cases, these reports contribute significantly to the collective advancement of healthcare, shaping the landscape of clinical research and patient management.

Abstract Submission Criteria & Eligibility

PRESENTATION REQUIREMENTS:

Authors presenting at the conference are required to cover their own registration, travel, and accommodation expenses. Please note that accepted abstracts will receive an acceptance email with instructions on how to register for the conference.

Abstracts will be compiled into conference books, which will be distributed to participants during the event.

In the event that a presenter is unable to attend, they must arrange for a qualified substitute to present their paper or poster. If such a change is needed, please notify our conference team promptly.

SUBMISSION OPTIONS:

Oral paper presentations will be allocated 30-minute time slots and will be organized into sessions based on thematic clustering. The keynote session will extend for 45 minutes, while workshops/special sessions will have a duration of 60 minutes. Symposia will also be allotted 60 minutes, followed by a 5-minute Q&A session.

Graduate and Master’s students may submit their abstracts for consideration in the poster and e-poster presentation category.

PhD students are invited to submit abstracts for the special Young Researcher’s Forum (YRF), poster, and e-poster presentation category. It's important to note that the YRF category encompasses brief oral presentations specifically tailored for Ph.D. students.

Extended abstract: Here's a revised version of the instructions in the Abstract Template format:

Title: Submissions Utilizing the Abstract Template

Abstract: This abstract outlines the requirements for submissions utilizing the Abstract Template in the specified category. Papers submitted in this category may encompass original empirical research, theoretical development, reviews, or critiques. The format ensures consistency and clarity in presentation, facilitating comprehension and evaluation for reviewers and readers alike.

Keywords: Abstract Template, submissions, empirical research, theoretical development, reviews, critiques.

These abstracts follow the structure of the Abstract Template, providing a concise overview of the respective topics while adhering to the prescribed format.

Participation/Presentation Option

Oral presentation: Oral presentations are open to topics spanning research, theory, professional practices, or personal experiences, presented in a succinct manner. Individuals with personal insights are encouraged to share narratives aiding everyday life. Speakers allotted a 30-minute slot should aim for a speaking duration of 20-25 minutes, while Keynote speakers should target 40-45 minutes, reserving the remainder for questions and discussion facilitated by the Session Chair.

Workshop: Workshop presenters will cover the same topic as the oral presentation but delve deeper into specialized techniques with detailed demonstrations. The workshop will last approximately 45-50 minutes, allowing for in-depth exploration. Participants keen on joining can do so alongside their teams, collaborating with their research coordinators. Special group waivers will be available upon registration for these workshops.

Poster presentation: The Infectious Diseases-2025 conference will be hosting a Student Poster Competition, aiming to foster the presentation of original research by students and recent graduates. Each presenter will have approximately 5-7 minutes to present their poster, which includes time for questions and answers. During the evaluation process, judges may pose questions to the presenters. This competition serves as an invaluable opportunity for emerging scientists to engage with the latest research in their field and enhance their skills as multidisciplinary researchers. Poster displays will be in hard copy format, measuring 1x1 meter.

For further information on Poster Presentation and Judging Criteria, please refer to the Poster Presentation Guidelines.

Webinar: The webinar presentation caters to interested attendees unable to participate in person due to scheduling conflicts or other commitments. In this alternative, the presenter can pre-record their session, which will then be featured during the webinar presentation session.

E-Poster: The e-Poster shares similarities with webinar presentations. During this session, participants will showcase their presentations in a poster format on the conference website. Additionally, the presenter's abstract will be featured in the conference souvenir and journal, complete with a DOI (Digital Object Identifier).

Exhibition: You're invited to participate in Infectious Diseases-2025, an event showcasing products and services from various organizations including drug manufacturers, clinical trial sites, management consultants, chemists, pharmacists, business delegates, and equipment manufacturers—both commercial and non-commercial.

Discover booth details and benefits by visiting "Why Exhibit with Us?" For further inquiries, reach out to contact@europeanmeets.com.

Advertisement: We are delighted to extend a warm welcome to all esteemed participants to the upcoming "12th International Conference on Infectious Diseases, Bacteriology, and Antibiotics," slated for May 21-22, 2025, in Paris, France. Our conference program serves as an indispensable guide throughout the event, providing invaluable information for attendees as they navigate the sessions and networking opportunities.

Advertising within the conference program presents a prime opportunity to showcase your brand and services to a targeted audience, ensuring maximum visibility and long-term business prospects. Explore our diverse range of advertisement options and competitive prices by reaching out to us at contact@primecongress.com.

Moreover, consider elevating your presence and demonstrating your commitment to the field through our Premium Sponsorship package or explore additional sponsorship opportunities tailored to your preferences. For more details on our sponsorship packages, kindly contact our program manager at contact@europeanmeets.com or reach out via WhatsApp at +44-2045861247.

Join us as we convene leading experts, researchers, and professionals to exchange insights, foster collaborations, and advance the fight against infectious diseases. We look forward to your participation in shaping this transformative event.

Young Research Award

Prestigious Award for Young Research’s at Infectious Diseases-2025– “Infectious Diseases, Bacteriology, and Antibiotics”

Infectious Diseases-2025 Committee is glad to announce “12th International Conference on Infectious Diseases, Bacteriology, and Antibiotics” on July 24-25, 2024 in Paris, France focusing on the theme: “Emerging Trends in Infectious Diseases Management: Innovations in Diagnosis and Treatment” Infectious Diseases-2025 developments are maintaining their momentum. Infectious Diseases Conference program delves into strategic discussions.

Infectious Diseases-2025 Young Scientist Awards:

Infectious Diseases-2025 Committee is intended to honour prestigious award for talented Young researchers, scientists, Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty in recognition of their outstanding contribution towards the conference theme. The Young Scientist Awards make every effort in providing a strong professional development opportunity for early career academicians by meeting experts to exchange and share their experiences on all aspects of Infectious Diseases.

Young Research’s Awards at Infectious Diseases-2025 for the Nomination: Young Researcher Forum - Outstanding Masters/Ph.D./Post Doctorate thesis work Presentation, only 25 presentations acceptable at Infectious Diseases-2025 young research forum.

Benefits

• Young Scientist Award recombination certificate and memento to the winners.
• Our conferences provide best Platform for your research through oral presentations.
• Learn about career improvement with all the latest technologies by networking.
• Young Scientists will get appropriate and timely information by this Forum.
• Platform for collaboration among young researchers for better development.
• Provide an opportunity for research interaction and established senior investigators across the globe in the field.
• Share the ideas with both eminent researchers and mentors.
• It’s a great privilege for young researchers to learn about the research areas for expanding their research knowledge.

Eligibility

• Young Investigators, Post-Graduate students, Post-doctoral fellows, Trainees, Junior faculty with a minimum of 5 years of research experience
• Presentation must be into scientific sessions of the conference.
• Each Young Researcher / Young Scientist can submit only one paper (as first author or co-author).
• Age limit-Under 35yrs
• All submissions must be in English.

Market Analysis

Market Size Over Time

The market for infectious diseases has demonstrated substantial growth over the years. Starting at $40 billion in 2018, it rose to $43 billion in 2019, $47 billion in 2020, $52 billion in 2021, $58 billion in 2022, and reached $65 billion in 2023. This growth highlights the increasing global focus on managing infectious diseases, driven by factors such as emerging pathogens and the need for better diagnostics and treatments.

The bacteriology market, though smaller in comparison, has also seen significant growth. It was valued at $15 billion in 2018 and grew to $16 billion in 2019, $18 billion in 2020, $21 billion in 2021, $25 billion in 2022, and $30 billion in 2023. This growth reflects advancements in bacterial research and the development of new diagnostic tools and therapies.

The antibiotics market has expanded steadily, starting at $25 billion in 2018 and increasing to $26 billion in 2019, $28 billion in 2020, $31 billion in 2021, $35 billion in 2022, and $40 billion in 2023. The ongoing need to combat bacterial infections and antibiotic resistance has fueled this market's growth.

Growth Rate Over Time

The infectious diseases market has shown strong growth rates, starting at 7.5% in both 2018 and 2019, then increasing to 9.3% in 2020, 10.6% in 2021, 11.5% in 2022, and 12.1% in 2023. This steady rise reflects the global prioritization of infectious disease management and the introduction of new technologies and treatments.

The growth rate for the bacteriology market has been impressive, starting at 6.7% in 2018 and 2019, then jumping to 12.5% in 2020, 16.7% in 2021, 19.0% in 2022, and 20.0% in 2023. This acceleration highlights the rapid advancements in bacterial research and increasing investments in this field.

Antibiotics have shown a consistent growth rate, starting at 4.0% in 2018 and 2019, then increasing to 7.7% in 2020, 10.7% in 2021, 12.9% in 2022, and 14.3% in 2023. This growth is driven by the continuous need for effective antibiotics and the development of new drugs to combat resistant bacterial strains.